Guymer RH - Search Results

1

Australian Angiogram Review Panel--monitoring the use of photodynamic therapy with verteporfin.

Bylsma GW, Harper CA, Dutton F, Johnson NC, Beaumont P, Guymer RH. Bylsma GW, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2006 Aug;34(6):550-6. doi: 10.1111/j.1442-9071.2006.01264.x. Clin Exp Ophthalmol. 2006. PMID: 16925702

2

Analysis of the Arg345Trp disease-associated allele of the EFEMP1 gene in individuals with early onset drusen or familial age-related macular degeneration.

Guymer RH, McNeil R, Cain M, Tomlin B, Allen PJ, Dip CL, Baird PN. Guymer RH, et al. Clin Exp Ophthalmol. 2002 Dec;30(6):419-23. doi: 10.1046/j.1442-9071.2002.00572.x. Clin Exp Ophthalmol. 2002. PMID: 12427233

3

New treatments in age-related macular degeneration.

Hooper CY, Guymer RH. Hooper CY, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Oct;31(5):376-91. doi: 10.1046/j.1442-9071.2003.00683.x. Clin Exp Ophthalmol. 2003. PMID: 14516424 Review.

4

Iris colour, ethnic origin and progression of age-related macular degeneration.

Nicolas CM, Robman LD, Tikellis G, Dimitrov PN, Dowrick A, Guymer RH, McCarty CA. Nicolas CM, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Dec;31(6):465-9. doi: 10.1046/j.1442-9071.2003.00711.x. Clin Exp Ophthalmol. 2003. PMID: 14641151

5

Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.

Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH. Essex RW, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2003 Dec;31(6):476-81. doi: 10.1046/j.1442-9071.2003.00714.x. Clin Exp Ophthalmol. 2003. PMID: 14641153 Clinical Trial.

6

HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?

Guymer RH, Chiu AW, Lim L, Baird PN. Guymer RH, et al. Surv Ophthalmol. 2005 Mar-Apr;50(2):194-206. doi: 10.1016/j.survophthal.2004.12.002. Surv Ophthalmol. 2005. PMID: 15749309 Review.

7

Treatment of age-related macular degeneration.

Bylsma GW, Guymer RH. Bylsma GW, et al. Among authors: guymer rh. Clin Exp Optom. 2005 Sep;88(5):322-34. doi: 10.1111/j.1444-0938.2005.tb06716.x. Clin Exp Optom. 2005. PMID: 16255691 Free article. Review.

8

Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study.

Owens SL, Bunce C, Brannon AJ, Xing W, Chisholm IH, Gross M, Guymer RH, Holz FG, Bird AC; Drusen Laser Study Group. Owens SL, et al. Among authors: guymer rh. Am J Ophthalmol. 2006 Feb;141(2):276-81. doi: 10.1016/j.ajo.2005.08.019. Am J Ophthalmol. 2006. PMID: 16458680 Clinical Trial.

9

Intravitreous injections.

Bylsma G, Guymer R, Qureshi S, Gin T, Allen P, Madhok P, McCombe M, Harper A. Bylsma G, et al. Clin Exp Ophthalmol. 2006 May-Jun;34(4):388-90. doi: 10.1111/j.1442-9071.2006.01231.x. Clin Exp Ophthalmol. 2006. PMID: 16764666 No abstract available.

10

Facts on fats.

Chong EW, Sinclair AJ, Guymer RH. Chong EW, et al. Among authors: guymer rh. Clin Exp Ophthalmol. 2006 Jul;34(5):464-71. doi: 10.1111/j.1442-9071.2006.01250.x. Clin Exp Ophthalmol. 2006. PMID: 16872345 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters